DA 5018

Known as: DA-5018 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
DA-5018, a recently synthesized capsaicin analog, appears to possess potent analgesic activity when administered topically. The… (More)
Is this relevant?
2001
2001
Studies of the effect of capsaicin (CAP) on the smooth muscle contractions have shown both contraction and relaxation in various… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Capsaicin (CAP) excites small sensory neurons, causing pain, neurogenic inflammation, and other visceral reflexes. These effects… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1999
1999
The antipruritic effect of DA-5018, a capsaicin derivative, was examined in mice. Male ICR mice were topically pretreated with… (More)
Is this relevant?
1999
1999
In the present work, the transport mechanism of a capsaicin derivative, DA-5018, through blood-brain barrier (BBB) has been… (More)
Is this relevant?
1998
1998
The pharmacokinetics of a non-narcotic analgesic, DA-5018, were compared after single intravenous (i.v.), subcutaneous (s.c… (More)
Is this relevant?
1997
1997
Analgesic effect of DA-5018, a new capsaicin derivative, was evaluated in various rat models of experimentally induced acute pain… (More)
Is this relevant?
1997
1997
The physicochemical and structural properties of new capsaicin derivative, DA-5018, were examined. The reference standard of this… (More)
Is this relevant?
1997
1997
A high-performance liquid chromatographic method was developed for the determination of a new non-narcotic analgesic, DA-5018 (I… (More)
Is this relevant?
1996
1996
The stability of DA-5018, a capsaicin analog as a new non-narcotic analgesic, in plasma, blood, 4% human serum albumin (HSA), and… (More)
Is this relevant?